相关实验视频

Updated: Jan 8, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies

Published on: July 3, 2025

通过TFAP2A调节的脂质代谢重编程,CES3促进NSCLC的进展

Pengfei Luo^1,2, Zirui Huang³, Sijuan Ding²

¹Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.

Journal of Cancer

|December 24, 2025

概括

转录因子AP-2α (TFAP2A) 通过调节碳素酶3 (CES3) 的升高,促进非小细胞肺癌 (NSCLC),导致扩散和入侵的增加. 针对这一TFAP2A/CES3途径为NSCLC提供了一个潜在的治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生化学

背景情况:

代谢重编程是非小细胞肺癌 (NSCLC) 的标志,有助于治疗耐药性.
在NSCLC中失调的脂质代谢为识别新生物标志物和治疗点提供了机会.

研究的目的:

调查碳糖酶3 (CES3) 在NSCLC进展中的作用及其与转录因子AP-2α (TFAP2A) 的关系.
探索针对TFAP2A/CES3轴作为NSCLC治疗策略的潜力.

主要方法:

在25个配对的NSCLC和相邻的正常组织上进行了RNA下一代测序.
功能性研究涉及NSCLC细胞中CES3和TFAP2A的淘汰和过度表达.
分析包括细胞增殖,入侵测定和脂质积累评估.

主要成果:

在NSCLC组织中发现,碳氧化酶3 (CES3) 的升高调节.
降低CES3抑制了NSCLC细胞的增殖和侵入,同时促进了脂质的积累.
转录因子AP-2α (TFAP2A) 在NSCLC上调,与糟糕的结果相关,并调节了CES3水平.
TFAP2A抑制抑制了NSCLC的进展和增加了脂质积累,CES3过度表达逆转了效应.

结论:

TFAP2A失调驱动NSCLC瘤发生通过CES3过度表达.
TFAP2A/CES3轴代表了非小细胞肺癌的一个有前途的治疗标.

关键词:

碳氧乙酶3 的作用.脂质新陈代谢脂质新陈代谢非小细胞肺癌的肺癌.它们的扩散和扩散.转录因子AP-2α.

更多相关视频

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Lipid Catabolism

Lipid Catabolism

Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...